DPP9 and nonpapillary renal cell carcinoma: Kun et al. revealed that DPP9 overexpression suppressed ferroptosis and induced resistance to sorafenib in ccRCC cells, which was largely dependent on the NRF2 transcriptional target SLC7A11 [44].